设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

2020 年第 1 期 第 15 卷

蒙医辨证治疗眩晕症的临床效果研究

Clinical effect of Mongolian medicine syndrome differentiation and treatment on vertigo

作者:那仁满都拉1季雪莲2甄瑾2聂童3宋洪涛4姜清秀5王小岩5

英文作者:

单位:1内蒙古自治区人民医院蒙医科,呼和浩特010017;2内蒙古自治区人民医院神经内科,呼和浩特010017;3内蒙古自治区人民医院中西医结合科,呼和浩特010017;4内蒙古自治区人民医院中医科,呼和浩特010017;5内蒙古医科大学蒙医药学院,呼和浩特010010

英文单位:

关键词:眩晕症;蒙医;辨证治疗

英文关键词:

  • 摘要:
  • 【摘要】目的    评价蒙医辨证治疗眩晕的临床效果。方法    选取2017年1月至2019年4月于内蒙古自治区人民医院病房及门诊诊治的眩晕症患者600例,最终将纳入疗效分析的570例眩晕症患者分为蒙药组(186例)、蒙西药组(183例)及西药组(201例)。蒙药组根据蒙医辨证再分为赫依、协日、巴达干、心、肾、肝、白脉型7个常见分型,分别给予阿嘎如-35、地格达-4汤、阿那日-5、阿敏-额尔敦、苏格木勒-10、古日古木-13、额尔敦-乌日勒口服;西药组给予尼莫地平口服;蒙西药组采用上述蒙药联合尼莫地平治疗。对患者治疗前后眩晕程度、头晕残障、蒙医证候等情况进行评分,治疗结束后1、3个月门诊复查随访患者复发情况。结果    蒙药组和蒙西药组总有效率高于西药组[87.1%(162/186)、88.0%(161/183)比80.1%(161/201)],3组间差异有统计学意义(χ2=6.385,P=0.041);总体疗效比较,7种证型不同治疗组间差异均无统计学意义(均P>0.05);各证型组间两两比较差异均无统计学意义(均P>0.05)。3组治疗前后眩晕程度量表、头晕残障量表、蒙医证候积分的减分值比较,蒙药组和蒙西药组的疗效略优于西药组,但差异均无统计学意义(均P>0.05);各证型3组间比较结果相似,差异均无统计学意义(均P>0.05)。治疗1、3个月3组复发率差异无统计学意义(均P>0.05)。3组均未出现严重不良反应。结论    蒙药治疗与蒙西药结合治疗眩晕总体疗效优于单用尼莫地平西药治疗,且安全性良好。

  • 【Abstract】Objective    To evaluate the clinical effect of Mongolian medicine syndrome differentiation and treatment on vertigo. Methods    Totally 600 patients with vertigo were admitted to Inner Mongolia People′s Hospital from January 2017 to April 2019; 570 of them who met the inclusion criteria were assigned to have Mongolian medicine(186 cases), Mongolian medicine plus western medicine(183 cases) and western medicine(201 cases). According to the syndrome differentiation of Mongolian medicine, 186 patients were divided into 7 common types: Heyi, Xieri, Badagan, heart, kidney, liver and Baimai type, which were respectively treated with Agaru-35, Digeda-4, Anari-5, Amin-Erdun, Sugemule-10, Gurigumu-13 and Erdun-wurile. Patients treated with western medicine took nimodipine. Severity of vertigo, dizziness and disability, symptoms of Mongolian medicine were assessed before and after treatment. Recurrence of vertigo was followed up 1 and 3 months after treatment. Results    The curative effect of Mongolian medicine with or without western medicine was significantly higher than that of western medicine[87.1%(162/186), 88.0%(161/183) vs 80.1%(161/201)](χ2=6.385,P=0.041). There was no significant difference of the curative effect regarding 7 syndrome types(all P>0.05). After treatment, the reductions of vertigo severity scale, dizziness and disability scale, Mongolian medicine syndrome scale were higher with Mongolian medicine than with western medicine, but the differences were not statistically significant(P>0.05); there were also no significant differences regarding 7 syndrome types(all P>0.05). The 1- and 3-month recurrence rates showed no significant differences between Mongolian medicine and western medicine(both P>0.05). No severe adverse event was reported in all groups. Conclusion    Mongolian medicine combined with western medicine treating vertigo shows a better curative effect than western medicine with favorable tolerance.

copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭
Baidu
map